August 20, 2013 — St. Jude Medical Inc. announced the acquisition of Endosense SA, a Switzerland-based company that has pioneered contact-force measurement in catheter ablation. The acquisition adds to the company’s electrophysiology portfolio and provides a robust platform for future product development.

Cardiac surgeons and cardiologists at the University of Maryland Heart Center are part of a multi-center clinical trial evaluating the efficacy of powering heart pumps through a skull-based connector behind the ear. Typically, these devices for patients with severe heart failure are energized through an electrical cord connected at an abdominal site.


August 19, 2013 — Medtronic Inc. announced the submission of its first pre-market approval (PMA) module to the U.S. Food and Drug Administration (FDA) for the IN.PACT Admiral drug-eluting balloon.

Cook Medical is again shipping its Zilver PTX drug-eluting peripheral stent to medical centers in the United States, Japan, Europe and other major markets. The shipments follow a brief period of unavailability due to a voluntary recall by Cook related to an issue with the stent’s delivery catheter that has been resolved.

IMRIS Inc. announced that a craniotomy recently performed on a 5-year-old boy with epilepsy was the 500th neurosurgical case at Cook Children's Medical Center in Fort Worth, Texas, using its intraoperative magnetic resonance imaging (iMRI) system. Cook Children's was the second children's hospital in the United States and fourth hospital worldwide with an IMRIS system that features a high-field MRI, which moves between surgical and diagnostic rooms using ceiling-mounted rails.

Aplio 500 received top ranking in the Ultrasound – General Imaging category in the 2013 Best in KLAS Awards: Medical Equipment & Infrastructure.

Patient enrollment has been initiated in a post-market registry for the Combo Dual Therapy Stent to evaluate its long-term safety and performance in routine clinical practice. The prospective, multicenter, all-comers REMEDEE Registry (Multicenter, Prospective, Clinical Outcomes After Deployment of the Abluminal Sirolimus Coated Bio-Engineered Stent — Combo Bio-Engineered Sirolimus Eluting Stent — Post Market Registry) will enroll 1,000 patients at nine European sites. As of today, more than 100 patients have already been enrolled.

Former President George W. Bush underwent heart surgery on the morning of Aug. 6, 2013, to receive a stent after an artery blockage was discovered during his annual physical. The routine physical included a stress test and an electrocardiogram. Abnormal results from the stress test prompted the former president to receive a computed tomography (CT) angiogram, and the surgery successfully took place one day after the blockage was discovered.

The first implantation of Tyrx Inc.’s new AigisRx R Fully Resorbable Antibacterial Envelope has taken place at the Vanderbilt Heart and Vascular Institute in Nashville, Tenn., by Christopher R. Ellis. The AigisRx R Antibacterial Envelope received U.S Food and Drug Administration (FDA) clearance on May 20, 2013.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now